Browsing Category
Healthcare Industry News
2467 posts
Inside Galderma’s €500m bond deal and what it reveals about the dermatology market’s financial momentum
Galderma raises €500M via a five-year eurobond to refinance IPO debt and strengthen its balance sheet. Discover what this means for GALD investors.
From Eli Lilly to Hims & Hers: what Kathryn Beiser’s move says about the telehealth platform’s ambitions
Hims & Hers Health appoints Kathryn Beiser as Chief Communications Officer. Explore what the move signals about strategy, growth, and investor sentiment.
Galderma share buyback: CHF 232m repurchase follows full exit by EQT, ADIA, and Auba Investment
Galderma repurchases CHF 232M in shares as EQT exits. Discover what the buyback and ownership shift mean for the dermatology company and investors.
What IFF’s Argentina fermentation hub reveals about the next phase of enzyme manufacturing
International Flavors & Fragrances Inc. expands Latin America bioscience operations with enzyme production and application labs. Discover what this means for industrial biotech.
Careteq (ASX: CTQ) raises A$2.2m at steep discount to fund acquisitions and clear debt as stock trades near 52-week low
Careteq (ASX: CTQ) raises A$2.2M via a two-tranche placement at A$0.005 per share to fund acquisitions, repay debt, and support working capital. Read the full analysis.
Can AI finally explain your lab results? Quest Diagnostics (NYSE: DGX) thinks so
Quest Diagnostics launches AI Companion powered by Google Gemini to explain lab results inside MyQuest. Discover how this could reshape patient-driven diagnostics.
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.
Paradigm reshapes leadership structure as Patient Square acquisition approaches and workers’ compensation strategy expands
Paradigm reshuffles leadership ahead of its Patient Square Capital acquisition. Discover what the changes signal for workers’ compensation and healthcare cost management.
Can nurse practitioners reshape Medicare care? Greater Good Health’s funding round says yes
Greater Good Health raises $20.5M Series B to expand nurse practitioner-led primary care. Discover why investors see value-based care as the future.
How Pharmavite is pushing Nature Made deeper into the fast-growing gut health supplements market
Nature Made launches SuperGreens and digestive enzymes as Pharmavite expands into the fast-growing gut health supplements market. Discover what this move means.